Webby RJ - Search Results

1

Cross-reactive Antibody Response to mRNA SARS-CoV-2 Vaccine After Recent COVID-19-Specific Monoclonal Antibody Therapy.

Schultz-Cherry S, McGargill MA, Thomas PG, Estepp JH, Gaur AH, Allen EK, Allison KJ, Tang L, Webby RJ, Cherry SD, Lin CY, Fabrizio T, Tuomanen EI, Wolf J; SJTRC Investigative Team. Schultz-Cherry S, et al. Among authors: webby rj. Open Forum Infect Dis. 2021 Aug 10;8(9):ofab420. doi: 10.1093/ofid/ofab420. eCollection 2021 Sep. Open Forum Infect Dis. 2021. PMID: 34557558 Free PMC article.

2

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

Webby RJ, Perez DR, Coleman JS, Guan Y, Knight JH, Govorkova EA, McClain-Moss LR, Peiris JS, Rehg JE, Tuomanen EI, Webster RG. Webby RJ, et al. Lancet. 2004 Apr 3;363(9415):1099-103. doi: 10.1016/S0140-6736(04)15892-3. Lancet. 2004. PMID: 15064027 Free PMC article.

3

Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses.

Andreansky SS, Stambas J, Thomas PG, Xie W, Webby RJ, Doherty PC. Andreansky SS, et al. Among authors: webby rj. J Virol. 2005 Apr;79(7):4329-39. doi: 10.1128/JVI.79.7.4329-4339.2005. J Virol. 2005. PMID: 15767433 Free PMC article.

4

An unexpected antibody response to an engineered influenza virus modifies CD8+ T cell responses.

Thomas PG, Brown SA, Yue W, So J, Webby RJ, Doherty PC. Thomas PG, et al. Among authors: webby rj. Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2764-9. doi: 10.1073/pnas.0511185103. Epub 2006 Feb 10. Proc Natl Acad Sci U S A. 2006. PMID: 16473934 Free PMC article.

5

NFkappaB negatively regulates interferon-induced gene expression and anti-influenza activity.

Wei L, Sandbulte MR, Thomas PG, Webby RJ, Homayouni R, Pfeffer LM. Wei L, et al. Among authors: webby rj. J Biol Chem. 2006 Apr 28;281(17):11678-84. doi: 10.1074/jbc.M513286200. Epub 2006 Mar 3. J Biol Chem. 2006. PMID: 16517601 Free PMC article.

6

Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses.

Thomas PG, Brown SA, Keating R, Yue W, Morris MY, So J, Webby RJ, Doherty PC. Thomas PG, et al. Among authors: webby rj. J Immunol. 2007 Mar 1;178(5):3091-8. doi: 10.4049/jimmunol.178.5.3091. J Immunol. 2007. PMID: 17312156

7

Protective memory responses are modulated by priming events prior to challenge.

Rutigliano JA, Morris MY, Yue W, Keating R, Webby RJ, Thomas PG, Doherty PC. Rutigliano JA, et al. Among authors: webby rj. J Virol. 2010 Jan;84(2):1047-56. doi: 10.1128/JVI.01535-09. Epub 2009 Nov 4. J Virol. 2010. PMID: 19889782 Free PMC article.

8

Intravenous zanamivir for oseltamivir-resistant 2009 H1N1 influenza.

Gaur AH, Bagga B, Barman S, Hayden R, Lamptey A, Hoffman JM, Bhojwani D, Flynn PM, Tuomanen E, Webby R. Gaur AH, et al. N Engl J Med. 2010 Jan 7;362(1):88-9. doi: 10.1056/NEJMc0910893. Epub 2009 Dec 23. N Engl J Med. 2010. PMID: 20032317 No abstract available.

9

Physiological numbers of CD4+ T cells generate weak recall responses following influenza virus challenge.

Thomas PG, Brown SA, Morris MY, Yue W, So J, Reynolds C, Webby RJ, Doherty PC. Thomas PG, et al. Among authors: webby rj. J Immunol. 2010 Feb 15;184(4):1721-7. doi: 10.4049/jimmunol.0901427. Epub 2010 Jan 8. J Immunol. 2010. PMID: 20061406 Free PMC article.

10

Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.

McCullers JA, Van De Velde LA, Allison KJ, Branum KC, Webby RJ, Flynn PM. McCullers JA, et al. Among authors: webby rj. Clin Infect Dis. 2010 Jun 1;50(11):1487-92. doi: 10.1086/652441. Clin Infect Dis. 2010. PMID: 20415539 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

473 results

Search Page